$2.75 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 177 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 64.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Sell | SPDR S&P 500 ETF TRput | $263,585,000 | -25.6% | 705,000 | -33.3% | 9.58% | -47.5% |
IWM | Sell | ISHARES TRput | $193,315,000 | +8.0% | 986,000 | -17.5% | 7.03% | -23.8% |
XLV | Sell | SELECT SECTOR SPDR TRput | $51,048,000 | -23.8% | 450,000 | -29.1% | 1.86% | -46.2% |
ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $44,507,000 | +100.9% | 1,182,446 | -1.1% | 1.62% | +41.7% |
INSP | Sell | INSPIRE MED SYS INC | $35,839,000 | +6.9% | 190,542 | -26.7% | 1.30% | -24.6% |
IBB | Sell | ISHARES TRput | $33,707,000 | -10.0% | 222,500 | -19.5% | 1.22% | -36.5% |
STAA | Sell | STAAR SURGICAL CO | $28,365,000 | +0.3% | 358,056 | -28.4% | 1.03% | -29.3% |
MDT | Sell | MEDTRONIC PLCcall | $23,428,000 | +2.5% | 200,000 | -9.1% | 0.85% | -27.7% |
VCEL | Sell | VERICEL CORP | $21,363,000 | +28.1% | 691,815 | -23.1% | 0.78% | -9.5% |
FXH | Sell | FIRST TR EXCHANGE TRADED FDput | $20,478,000 | -41.2% | 190,000 | -48.3% | 0.74% | -58.6% |
PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $20,130,000 | +104.0% | 776,030 | -22.4% | 0.73% | +43.8% |
XENT | Sell | INTERSECT ENT INC | $19,596,000 | +39.6% | 855,723 | -0.6% | 0.71% | -1.7% |
ALXN | Sell | ALEXION PHARMACEUTICALS INC | $19,358,000 | -13.8% | 123,896 | -36.9% | 0.70% | -39.2% |
IVC | Sell | INVACARE CORP | $14,803,000 | +17.9% | 1,653,941 | -0.9% | 0.54% | -16.8% |
QTNT | Sell | QUOTIENT LTD | $14,423,000 | -8.1% | 2,768,249 | -9.4% | 0.52% | -35.2% |
PSNL | Sell | PERSONALIS INC | $14,270,000 | +23.9% | 389,771 | -26.6% | 0.52% | -12.5% |
AFIB | Sell | ACUTUS MED INC | $13,531,000 | -15.1% | 473,146 | -11.6% | 0.49% | -40.1% |
CNMD | Sell | CONMED CORP | $12,746,000 | -18.6% | 113,802 | -42.8% | 0.46% | -42.6% |
Sell | DERMTECH INC | $12,719,000 | +164.3% | 392,078 | -2.6% | 0.46% | +86.3% | |
PPD | Sell | PPD INC | $9,667,000 | -56.4% | 282,500 | -52.9% | 0.35% | -69.3% |
QTRX | Sell | QUANTERIX CORP | $6,565,000 | +28.7% | 141,175 | -6.6% | 0.24% | -9.1% |
SILK | Sell | SILK RD MED INC | $6,197,000 | -10.8% | 98,400 | -4.8% | 0.22% | -37.2% |
TXG | Sell | 10X GENOMICS INC | $6,018,000 | -35.4% | 42,500 | -43.1% | 0.22% | -54.4% |
BLFS | Sell | BIOLIFE SOLUTIONS INC | $5,984,000 | +33.4% | 150,000 | -3.2% | 0.22% | -5.6% |
KIDS | Sell | ORTHOPEDIATRICS CORP | $5,999,000 | -26.8% | 145,440 | -18.5% | 0.22% | -48.3% |
IMVT | Sell | IMMUNOVANT INC | $5,483,000 | -2.0% | 118,702 | -25.4% | 0.20% | -30.9% |
Sell | CYTOKINETICS INCnote 4.000%11/1 | $5,397,000 | -2.9% | 25,000 | -99.0% | 0.20% | -31.7% | |
CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $4,907,000 | +21.7% | 102,994 | -10.8% | 0.18% | -14.4% |
Sell | TRILLIUM THERAPEUTICS INC | $3,155,000 | -29.4% | 214,487 | -31.8% | 0.12% | -50.0% | |
BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,073,000 | +23.9% | 412,419 | -42.9% | 0.11% | -12.5% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $2,926,000 | -58.1% | 40,000 | -55.6% | 0.11% | -70.6% |
AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,602,000 | -35.1% | 389,571 | -51.0% | 0.10% | -54.1% |
KURA | Sell | KURA ONCOLOGY INC | $2,476,000 | -20.8% | 75,800 | -25.7% | 0.09% | -44.1% |
FOLD | Sell | AMICUS THERAPEUTICS INC | $1,344,000 | -39.8% | 58,200 | -63.2% | 0.05% | -57.4% |
Sell | GOSSAMER BIO INCnote 5.000% 6/0 | $455,000 | -11.7% | 5,000 | -99.0% | 0.02% | -37.0% | |
OTIC | Exit | OTONOMY INCcall | $0 | – | -800 | -100.0% | 0.00% | – |
PRLD | Exit | PRELUDE THERAPEUTICS INC | $0 | – | -5,000 | -100.0% | -0.01% | – |
TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -10,000 | -100.0% | -0.01% | – |
SVRA | Exit | SAVARA INC | $0 | – | -266,570 | -100.0% | -0.02% | – |
PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.02% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS INCput | $0 | – | -116,800 | -100.0% | -0.02% | – |
LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -100,000 | -100.0% | -0.02% | – |
SAVA | Exit | CASSAVA SCIENCES INCcall | $0 | – | -50,000 | -100.0% | -0.03% | – |
CODX | Exit | CO-DIAGNOSTICS INCput | $0 | – | -50,000 | -100.0% | -0.04% | – |
AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.04% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -10,000 | -100.0% | -0.04% | – |
AGTC | Exit | APPLIED GENETIC TECHNOLOGIES | $0 | – | -176,411 | -100.0% | -0.04% | – |
CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -488,200 | -100.0% | -0.04% | – |
CRBP | Exit | CORBUS PHARMACEUTICALS HLDGSput | $0 | – | -500,000 | -100.0% | -0.05% | – |
TMDX | Exit | TRANSMEDICS GROUP INCput | $0 | – | -75,000 | -100.0% | -0.05% | – |
EOLS | Exit | EVOLUS INCput | $0 | – | -294,500 | -100.0% | -0.06% | – |
PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -148,949 | -100.0% | -0.07% | – |
FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -322,452 | -100.0% | -0.08% | – |
INO | Exit | INOVIO PHARMACEUTICALS INCput | $0 | – | -130,300 | -100.0% | -0.08% | – |
RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -886,222 | -100.0% | -0.10% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -144,200 | -100.0% | -0.11% | – |
ARDX | Exit | ARDELYX INC | $0 | – | -418,908 | -100.0% | -0.11% | – |
AVTR | Exit | AVANTOR INC | $0 | – | -105,000 | -100.0% | -0.12% | – |
CSII | Exit | CARDIOVASCULAR SYS INC DELcall | $0 | – | -60,000 | -100.0% | -0.12% | – |
GNMK | Exit | GENMARK DIAGNOSTICS INCput | $0 | – | -175,000 | -100.0% | -0.13% | – |
LYRA | Exit | LYRA THERAPEUTICS INC | $0 | – | -226,703 | -100.0% | -0.13% | – |
INCY | Exit | INCYTE CORPcall | $0 | – | -30,000 | -100.0% | -0.14% | – |
DIN | Exit | DINE BRANDS GLOBAL INCcall | $0 | – | -50,000 | -100.0% | -0.14% | – |
VAPO | Exit | VAPOTHERM INCput | $0 | – | -100,000 | -100.0% | -0.15% | – |
KRMD | Exit | REPRO MED SYS INC | $0 | – | -408,516 | -100.0% | -0.15% | – |
ATRC | Exit | ATRICURE INCcall | $0 | – | -75,000 | -100.0% | -0.15% | – |
RCL | Exit | ROYAL CARIBBEAN GROUPcall | $0 | – | -50,000 | -100.0% | -0.17% | – |
CORT | Exit | CORCEPT THERAPEUTICS INCcall | $0 | – | -188,900 | -100.0% | -0.17% | – |
CUTR | Exit | CUTERA INC | $0 | – | -183,275 | -100.0% | -0.18% | – |
OSUR | Exit | ORASURE TECHNOLOGIES INCcall | $0 | – | -310,200 | -100.0% | -0.20% | – |
ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -150,000 | -100.0% | -0.20% | – |
ITMR | Exit | ITAMAR MED LTDsponsored ads | $0 | – | -190,074 | -100.0% | -0.20% | – |
EW | Exit | EDWARDS LIFESCIENCES CORPput | $0 | – | -50,000 | -100.0% | -0.21% | – |
EXAS | Exit | EXACT SCIENCES CORPcall | $0 | – | -40,000 | -100.0% | -0.21% | – |
HOLX | Exit | HOLOGIC INCcall | $0 | – | -62,500 | -100.0% | -0.21% | – |
TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -57,581 | -100.0% | -0.22% | – |
BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -176,639 | -100.0% | -0.23% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -31,838 | -100.0% | -0.23% | – |
AAL | Exit | AMERICAN AIRLS GROUP INCcall | $0 | – | -373,800 | -100.0% | -0.24% | – |
LHCG | Exit | LHC GROUP INC | $0 | – | -22,497 | -100.0% | -0.25% | – |
ABMD | Exit | ABIOMED INCput | $0 | – | -17,500 | -100.0% | -0.25% | – |
GKOS | Exit | GLAUKOS CORPcall | $0 | – | -100,000 | -100.0% | -0.26% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -87,469 | -100.0% | -0.27% | – |
NVTA | Exit | INVITAE CORP | $0 | – | -122,000 | -100.0% | -0.27% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -100,000 | -100.0% | -0.31% | – |
FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -812,757 | -100.0% | -0.31% | – |
TECH | Exit | BIO-TECHNE CORPput | $0 | – | -25,000 | -100.0% | -0.32% | – |
MMM | Exit | 3M COcall | $0 | – | -40,000 | -100.0% | -0.33% | – |
OTIC | Exit | OTONOMY INC | $0 | – | -1,671,748 | -100.0% | -0.35% | – |
LSF | Exit | LAIRD SUPERFOOD INC | $0 | – | -150,000 | -100.0% | -0.36% | – |
MRNA | Exit | MODERNA INCcall | $0 | – | -100,000 | -100.0% | -0.36% | – |
INSP | Exit | INSPIRE MED SYS INCcall | $0 | – | -65,000 | -100.0% | -0.43% | – |
IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -100,000 | -100.0% | -0.44% | – |
AMGN | Exit | AMGEN INCcall | $0 | – | -40,000 | -100.0% | -0.52% | – |
ISRG | Exit | INTUITIVE SURGICAL INCput | $0 | – | -15,000 | -100.0% | -0.55% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.59% | – |
MASI | Exit | MASIMO CORPput | $0 | – | -55,000 | -100.0% | -0.67% | – |
COO | Exit | COOPER COS INC | $0 | – | -80,000 | -100.0% | -1.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.